Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3073% above fair value
$319.11−1.51 (-0.47%)
Close on Nov 17, 2026Market cap $12.58BP/E 80.4Yield –
Penumbra operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Penumbra's operating income for the twelve months ending Sep 30, 2026 was $189.25M, up 9.5% year over year. For fiscal 2025 it was $189.25M, up 1939.5% from the year before. Over ten years it grew 46.4% a year on average. The highest annual figure on record is $189.25M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $189.25M | +1939.5% |
| FY2024 | Dec 31, 2024 | $9.28M | -87.4% |
| FY2023 | Dec 31, 2023 | $73.55M | +1109.3% |
| FY2022 | Dec 31, 2022 | $6.08M | – |
| FY2021 | Dec 31, 2021 | -$7.50M | – |
| FY2020 | Dec 31, 2020 | -$38.94M | -182.0% |
| FY2019 | Dec 31, 2019 | $47.51M | – |
| FY2018 | Dec 31, 2018 | -$852.00K | -173.1% |
| FY2017 | Dec 31, 2017 | $1.17M | – |
| FY2016 | Dec 31, 2016 | -$1.35M | -132.3% |
| FY2015 | Dec 31, 2015 | $4.18M | +38.9% |
| FY2014 | Dec 31, 2014 | $3.01M | – |
| FY2013 | Dec 31, 2013 | -$1.13M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $50.74M | +3.9% |
| Q2 FY2026 | Jun 30, 2026 | $41.04M | +0.5% |
| Q1 FY2026 | Mar 31, 2026 | $38.23M | -5.2% |
| Q4 FY2025 | Dec 31, 2025 | $59.23M | +38.5% |
| Q3 FY2025 | Sep 30, 2025 | $48.84M | +38.1% |
| Q2 FY2025 | Jun 30, 2025 | $40.83M | – |
| Q1 FY2025 | Mar 31, 2025 | $40.35M | +233.4% |
| Q4 FY2024 | Dec 31, 2024 | $42.78M | +22.1% |
| Q3 FY2024 | Sep 30, 2024 | $35.36M | +180.1% |
| Q2 FY2024 | Jun 30, 2024 | -$80.96M | -552.6% |
| Q1 FY2024 | Mar 31, 2024 | $12.10M | +51.1% |
| Q4 FY2023 | Dec 31, 2023 | $35.03M | +624.8% |
| Q3 FY2023 | Sep 30, 2023 | $12.63M | +132.3% |
| Q2 FY2023 | Jun 30, 2023 | $17.89M | – |
| Q1 FY2023 | Mar 31, 2023 | $8.01M | – |
| Q4 FY2022 | Dec 31, 2022 | $4.83M | – |
| Q3 FY2022 | Sep 30, 2022 | $5.43M | -38.1% |
| Q2 FY2022 | Jun 30, 2022 | -$139.00K | -101.3% |
| Q1 FY2022 | Mar 31, 2022 | -$4.05M | -130.1% |
| Q4 FY2021 | Dec 31, 2021 | -$40.06M | – |
| Q3 FY2021 | Sep 30, 2021 | $8.78M | – |
| Q2 FY2021 | Jun 30, 2021 | $10.31M | – |
| Q1 FY2021 | Mar 31, 2021 | $13.46M | +2107.0% |
| Q4 FY2020 | Dec 31, 2020 | -$1.75M | -116.5% |
| Q3 FY2020 | Sep 30, 2020 | -$20.16M | -255.3% |
| Q2 FY2020 | Jun 30, 2020 | -$17.65M | -237.9% |
| Q1 FY2020 | Mar 31, 2020 | $610.00K | -94.5% |
| Q4 FY2019 | Dec 31, 2019 | $10.58M | +58.6% |
| Q3 FY2019 | Sep 30, 2019 | $12.98M | – |
| Q2 FY2019 | Jun 30, 2019 | $12.80M | +37.9% |
| Q1 FY2019 | Mar 31, 2019 | $11.15M | +175.7% |
| Q4 FY2018 | Dec 31, 2018 | $6.67M | +73.0% |
| Q3 FY2018 | Sep 30, 2018 | -$20.85M | -3152.6% |
| Q2 FY2018 | Jun 30, 2018 | $9.28M | – |
| Q1 FY2018 | Mar 31, 2018 | $4.05M | – |
| Q4 FY2017 | Dec 31, 2017 | $3.86M | – |
| Q3 FY2017 | Sep 30, 2017 | $683.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.33M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.15M | – |
See a number that looks wrong?